2014
DOI: 10.1111/ene.12445
|View full text |Cite
|
Sign up to set email alerts
|

In vivo decreased dopamine transporter uptake in corticobasal degeneration presenting with primary progressive aphasia without parkinsonism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…However, we also know that 123 I FP-CIT SPECT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms [39], so this distinction solely on the basis of imaging is not without a risk of misdiagnosis. In vivo decreased dopamine transporter uptake in corticobasal degeneration presenting with primary progressive aphasia without parkinsonism has been demonstrated [40]. However, in some instances, normal 123 I FP-CIT SPECT is seen in neuropathologically confirmed corticobasal degeneration [41•]; so normal 123 I FP-CIT SPECT does not necessarily rule out CBGD.…”
Section: Fp-cit Spect Imaging In Other Dementiasmentioning
confidence: 99%
“…However, we also know that 123 I FP-CIT SPECT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms [39], so this distinction solely on the basis of imaging is not without a risk of misdiagnosis. In vivo decreased dopamine transporter uptake in corticobasal degeneration presenting with primary progressive aphasia without parkinsonism has been demonstrated [40]. However, in some instances, normal 123 I FP-CIT SPECT is seen in neuropathologically confirmed corticobasal degeneration [41•]; so normal 123 I FP-CIT SPECT does not necessarily rule out CBGD.…”
Section: Fp-cit Spect Imaging In Other Dementiasmentioning
confidence: 99%